 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 01, 2019 |
| Title |
RNA expression data from calcified human carotid atherosclerotic plaques |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Although unstable atherosclerosis in the carotid bifurcation is a significant etiology behind ischemic stroke, clinical imaging methods to distinguish stable from vulnerable lesions are lacking and selection of patients for stroke-preventive intervention still relies on surrogate variables with moderate predictive power, such as the degree of luminal narrowing. Here we combined clinical and diagnostic imaging information by comuted tomography to select patients with calcified plaques for large scale molecular analysis, in an effort to increase our understanding of the pathophysiology behind carotid plaque instability as related to patient- and plaque- phenotype.
|
| |
|
| Overall design |
Patients undergoing surgery for high-grade (>50% NASCET) carotid stenosis at the Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden were consecutively enrolled in the study and clinical data recorded on admission. Carotid computed tomography angiography (CTA) was performed as a pre-operative routine at the admitting hospital using site-specific image acquisition protocols. Carotid endarterectomies (carotid plaques) were collected at surgery and retained within the Biobank of Karolinska Endarterectomies (BiKE). Tissues were frozen at -80°C immediately after surgery and RNA was prepared using Qiazol Lysis Reagent (Qiagen, Hilden, Germany) and purified by RNeasy Mini kit (Qiagen), including DNase digestion. The RNA concentration was measured using Nanodrop ND-1000 (Thermo Scientific, Waltham, MA) and quality estimated by a Bioanalyzer capillary electrophoresis system (Agilent Technologies, Santa Clara, CA). For microarrays, only RNA of good integrity with RIN>7, A260/A280 ratio between 1.8-2.1, A260/230 0.7-1.5 and concentration about 50-500 ng/μl was used, as per standards recommended for whole transcript arrays. Robust multi-array average normalization was performed and processed gene expression data was returned in log2-scale. All human samples were collected with informed consent from patients or organ donors’ guardians; studies were approved by the regional Ethical Committee and follow the guidelines of the Declaration of Helsinki.
|
| |
|
| Contributor(s) |
Karlöf E, Seime T, Dias N, Lengquist M, Witasp A, Almqvist H, Kronqvist M, Gådin JR, Odeberg J, Maegdefessel L, Stenvinkel P, Perisic Matic L, Hedin U |
| Citation(s) |
31109707, 34063989, 35494231, 36188622 |
| Submission date |
Jan 28, 2019 |
| Last update date |
Oct 21, 2022 |
| Contact name |
Jesper Robert Gådin |
| E-mail(s) |
jesper.r.gadin@ki.se
|
| Organization name |
Karolinska Institutet
|
| Department |
Department of Medicine
|
| Lab |
Atherosclerosis Research Unit
|
| Street address |
CMM, L8:02 Karolinska Universitetessjukhuset, Solna
|
| City |
Stockholm |
| ZIP/Postal code |
171 76 |
| Country |
Sweden |
| |
|
| Platforms (1) |
| GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
|
| Samples (40)
|
|
| Relations |
| BioProject |
PRJNA517476 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE125771_RAW.tar |
951.1 Mb |
(http)(custom) |
TAR (of CEL) |
| Processed data included within Sample table |
|
|
|
|
 |
Less...
More...